Clinical Trials Directory

Trials / Sponsors / TaiMed Biologics Inc.

TaiMed Biologics Inc.

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingHIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
HIV -1 Infection
Phase 22025-12-16
CompletedTMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals
HIV-1-infection
Phase 1 / Phase 22022-07-05
CompletedDose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants
HIV-1-infection
Phase 12019-12-14
CompletedStudy of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection
HIV-1-infection
Phase 32019-05-30
TerminatedStudy of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers
Human Immunodeficiency Virus
Phase 12016-11-21
CompletedIbalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
HIV
Phase 32016-03-01
CompletedIbalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
HIV
Phase 32015-08-01
CompletedSafety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
Prevention of Infection With HIV-1
Phase 12011-02-01
CompletedDose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV
HIV
Phase 22008-08-01